This event offers
1.0 CME credit
to attendees.
Accreditation Info:
ACCME.
Additional Information
Examine the latest updates in novel-targeted and immuno-therapeutic treatment approaches
Identify potential unique adverse events associated with novel therapeutics and implement patient-centric education, monitoring, and reporting protocols
Integrate best practices for patient education and communication, including strategies for discussing treatment options, concerns and monitoring for/managing adverse events
Establish best practices for peer-to-peer expert communication for optimal multidisciplinary care of patients with Cutaneous Squamous Cell Carcinoma.
